 Idiopathic L-tryptophan-associated eosinophilic fasciitis L-tryptophan contamination causative association ingestion levotryptophan L-tryptophan eosinophilia-myalgia syndrome EMS new entity peripheral blood eosinophilia myalgias constitutional symptoms cutaneous edema fibrosis levotryptophan preparations single manufacturing company October June EMS cases study patients cutaneous fibrosis history levotryptophan use Levotryptophan ingestion onset disease patients eosinophilic fascilitis EF patients localized scleroderma none patients systemic sclerosis onset levotryptophan-associated cutaneous disease availability levotryptophan preparations patients patient levotryptophan-associated generalized morphea sclerosus et atrophicus acanthosis nigricans findings patients EMS addition clinical laboratory features levotryptophan-associated EF idiopathic EF Myalgias muscle weakness paresthesias morpheaform plaques cutaneous ulcers livedo reticularis common patients levotryptophan-associated EF levotryptophan-associated EF scleroderma present presumed date levotryptophan availability clinical spectrum cutaneous fibrosis ingestion levotryptophan morphea EF similar identical idiopathic counterparts